Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)-standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgery.
Byrne BE, Siaw-Acheampong K, Evans O, Taylor J, Huddy F, Nilsson M, Griffiths EA, Low D, Gossage J, Dunn J, Zeki S, Markar S, Avery K, Blazeby JM, Cockbain A, Moss C, van Hemelrijck M, Andreyev J, Davies AR; RESTORE Delphi study group. Byrne BE, et al. Br J Surg. 2024 Nov 27;111(12):znae286. doi: 10.1093/bjs/znae286. Br J Surg. 2024. PMID: 39657739
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.
Kishnani PS, Byrne BJ, Claeys KG, Díaz-Manera J, Dimachkie MM, Kushlaf H, Mozaffar T, Roberts M, Schoser B, Hummel N, Kopiec A, Holdbrook F, Shohet S, Toscano A; PROPEL Study Group. Kishnani PS, et al. Among authors: byrne bj. J Patient Rep Outcomes. 2024 Nov 13;8(1):132. doi: 10.1186/s41687-024-00805-w. J Patient Rep Outcomes. 2024. PMID: 39535661 Free PMC article. Clinical Trial.
Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease.
Byrne BJ, Parenti G, Schoser B, van der Ploeg AT, Do H, Fox B, Goldman M, Johnson FK, Kang J, Mehta N, Mondick J, Sheikh MO, Sitaraman Das S, Tuske S, Brudvig J, Weimer JM, Mozaffar T. Byrne BJ, et al. Front Neurol. 2024 Oct 18;15:1451512. doi: 10.3389/fneur.2024.1451512. eCollection 2024. Front Neurol. 2024. PMID: 39494167 Free PMC article.
Differences in Pediatricians' Income by Sex Over Time.
Frintner MP, Freed GL, Byrne BJ, Leslie LK, Starmer AJ, Gottschlich EA, Olson LM. Frintner MP, et al. Among authors: byrne bj. Pediatrics. 2024 Nov 1;154(5):e2024066240. doi: 10.1542/peds.2024-066240. Pediatrics. 2024. PMID: 39468944
Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy.
Servais L, Lair LL, Connolly AM, Byrne BJ, Chen KS, Coric V, Qureshi I, Durham S, Campbell DJ, Maclaine G, Marin J, Bechtold C. Servais L, et al. Among authors: byrne bj. Int J Mol Sci. 2024 Sep 24;25(19):10273. doi: 10.3390/ijms251910273. Int J Mol Sci. 2024. PMID: 39408601 Free PMC article. Review.
The dimer of human SVCT1 is key for transport function.
Woubshete M, Chan LI, Diallinas G, Byrne B. Woubshete M, et al. Among authors: byrne b. Biochim Biophys Acta Biomembr. 2024 Dec;1866(8):184390. doi: 10.1016/j.bbamem.2024.184390. Epub 2024 Oct 4. Biochim Biophys Acta Biomembr. 2024. PMID: 39369805 Free article.
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study.
Phillips TJ, Carlo-Stella C, Morschhauser F, Bachy E, Crump M, Trněný M, Bartlett NL, Zaucha J, Wrobel T, Offner F, Humphrey K, Relf J, Filézac de L'Etang A, Carlile DJ, Byrne B, Qayum N, Lundberg L, Dickinson M. Phillips TJ, et al. Among authors: byrne b. J Clin Oncol. 2024 Oct 4:JCO2302470. doi: 10.1200/JCO.23.02470. Online ahead of print. J Clin Oncol. 2024. PMID: 39365960
Preparing Physician-Scientists for the Future of Academic Medicine.
Burns AM, Moore DJ, Rassbach CE, Boyer D, Gildner C, Byrne B, Harris KW, Iness A, Powell WT, Callaway D, Lajiness J, Forster CS, Orange JS, Ackerman KG, Thammasitboon S. Burns AM, et al. Among authors: byrne b. Pediatrics. 2024 Nov 1;154(5):e2024067045. doi: 10.1542/peds.2024-067045. Pediatrics. 2024. PMID: 39359193
Feasibility of the Understanding and Managing Adult ADHD Programme: open-access online group psychoeducation and acceptance and commitment therapy for adults with attention-deficit hyperactivity disorder.
Seery C, Leonard-Curtin A, Naismith L, King N, O'Donnell F, Byrne B, Boyd C, Kilbride K, Wrigley M, McHugh L, Bramham J. Seery C, et al. Among authors: byrne b. BJPsych Open. 2024 Sep 26;10(5):e163. doi: 10.1192/bjo.2024.743. BJPsych Open. 2024. PMID: 39324244 Free PMC article.
991 results